These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10747964)

  • 21. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
    Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing interaction of a fluorescent ligand with HIV TAR RNA.
    Qi L; Zhang J; He T; Huo Y; Zhang ZQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA.
    Fourmy D; Recht MI; Puglisi JD
    J Mol Biol; 1998 Mar; 277(2):347-62. PubMed ID: 9514735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
    Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
    J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Tat protein is able to efficiently transactivate the HIV-2 LTR through a TAR RNA element lacking both dinucleotide bulge binding sites.
    Rhim H; Rice AP
    Virology; 1995 Jan; 206(1):673-8. PubMed ID: 7831824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic characterization of TAR RNA-Tat peptide and neomycin interactions by acoustic wave biosensor.
    Tassew N; Thompson M
    Biophys Chem; 2003 Dec; 106(3):241-52. PubMed ID: 14556896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
    Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
    J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.
    Ranjan N; Kumar S; Watkins D; Wang D; Appella DH; Arya DP
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5689-93. PubMed ID: 24012122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleobase modified neamines with a lysine as a linker, their inhibition specificity for TAR-Tat derived from HIV-1.
    Inoue R; Watanabe K; Katou T; Ikezawa Y; Hamasaki K
    Bioorg Med Chem; 2015 May; 23(9):2139-47. PubMed ID: 25819332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
    Huq I; Tamilarasu N; Rana TM
    Nucleic Acids Res; 1999 Feb; 27(4):1084-93. PubMed ID: 9927743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains.
    Gelus N; Bailly C; Hamy F; Klimkait T; Wilson WD; Boykin DW
    Bioorg Med Chem; 1999 Jun; 7(6):1089-96. PubMed ID: 10428378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
    Mujeeb A; Parslow TG; Yuan YC; James TL
    J Biomol Struct Dyn; 1996 Feb; 13(4):649-60. PubMed ID: 8906885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.